Tenax Therapeutics

Tenax Therapeutics is a company listed under the stock ticker TENX (US).

View the org chart displaying its 10 main executives

Most searched biographies at Tenax Therapeutics

• Christopher Giordano, Chief Executive Officer and Director
• Gerald Proehl, Chairman of the Board
• Robyn Hunter, Director

Create your alert
to follow the executive moves at Tenax Therapeutics.

Tenax Therapeutics has 2,281 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Tenax Therapeutics

Social media about Tenax Therapeutics

• Tenax Therapeutics on Wikipedia, Google News & Yahoo Finance
• Tenax Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Christopher Giordano

Call Tenax Therapeutics at +1 919...

View the org chart

Register to receive your alert

Report an error